HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS

被引：0
|
作者：
Koka, N. S. [1 ]
Syed, A. A. [1 ]
Ahmad, M. [1 ]
Patel, K. [1 ]
Nair, S. [1 ]
Shah, S. [1 ]
机构：
[1] Market Access Solut LLC LTD MKTXS, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA169
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [41] Reimbursement of Targeted Cancer Therapies Within 3 Different European Health Care Systems
    Mihajlovic, Jovan
    Dolk, Christiaan
    Tolley, Keith
    Simoens, Steven
    Postma, Maarten J.
    CLINICAL THERAPEUTICS, 2015, 37 (02) : 474 - 480
  • [42] HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR REGENERATIVE MEDICINE AND CELLULAR THERAPIES: LESSONS FROM A MULTI-MARKET HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT REVIEW
    Faulkner, E. C.
    Fernandez, M.
    Spinner, D. S.
    VALUE IN HEALTH, 2011, 14 (07) : A337 - A338
  • [43] REIMBURSEMENT OUTCOMES FOR COMBINATION THERAPIES VS MONOTHERAPIES IN LUNG CANCER AND MULTIPLE MYELOMA IN THE TOP FIVE EUROPEAN MARKETS
    Izmirlieva, M. A.
    Reinaud, F.
    Taiyeb, M.
    Ando, G.
    VALUE IN HEALTH, 2022, 25 (01) : S7 - S7
  • [44] Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia - Reimbursement scenario analysis
    Toomeh, Elias
    Sabbah, Ream
    Englund, Anne-Maree
    Kottege, Darin
    Bohensky, Megan
    Spiteri, Carmel
    Sales, Owen
    Davies, Neil
    Nagda, Nirav
    Lucherini, Stefano
    Hughes, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 165 - 165
  • [45] Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries
    Efthymiadou, Olina
    Kanavos, Panos
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [46] HEALTH TECHNOLOGY ASSESSMENT, PRICE AND REIMBURSEMENT REVIEW FOR ORPHAN DRUGS IN ITALY
    Tavella, F.
    Korchagina, D.
    Rodrigues, J.
    Remuzat, C.
    VALUE IN HEALTH, 2014, 17 (07) : A540 - A540
  • [47] Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies
    Castillo-Labordo, Carla
    Silva-Illanes, Nicolas
    REVISTA MEDICA DE CHILE, 2014, 142 (01) : S33 - S38
  • [48] Harmonization of evidence requirements for health technology assessment in reimbursement decision making
    Hutton, John
    Trueman, Paul
    Facey, Karen
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 511 - 517
  • [49] HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT OF MEDICAL DEVICES IN ENGLAND, FRANCE, AND GERMANY
    Heptinstall, A.
    Teague, R.
    VALUE IN HEALTH, 2022, 25 (12) : S343 - S344
  • [50] Health Technology Assessment and Appraisal of Therapies for Rare Diseases
    Iskrov, Georgi
    Miteva-Katrandzhieva, Tsonka
    Stefanov, Rumen
    RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION, 2017, 1031 : 221 - 231
12345